.png)
3D Cancer model
Cell cultures grown in 2D cannot replicate living tissues' complex environment. The 3D tumor spheroid platform developed by Apricell offers a more accurate and physiologically relevant model, simulating the architecture and cellular dynamics of solid tumors. Cancer biology research, high-throughput drug screening, and personalized therapy development can all be conducted using these spheroids, which replicate key tumor features, such as nutrient gradients and cell heterogeneity.
Spheroid model
Spheroids are 3D cell clusters that closely resemble real tissues or microtumors, offering a more realistic environment than traditional 2D cultures. These in vitro models, often made from cancer or other specialized cells, have become valuable tools for studying tissue behavior and disease in a setting that mimics in vivo conditions.
Organoid model
Organoids are 3D miniaturized structures grown from stem or tissue-derived cells that self-organize to mimic the architecture and function of real organs. These in vitro models provide a powerful platform to study human biology and disease in a controlled lab environment.
Patient-derived organoid
Patient-derived organoids (PDOs) are 3D cultures grown from a patient's own tumor tissue, offering a personalized model for studying cancer. These organoids closely mimic the structure and behavior of real tumors, making them powerful tools for understanding disease progression and testing drug responses tailored to individual patients.
Patient-derived xenograft organoid
Patient-derived xenograft organoids (PDXOs) are 3D cultures created from patient tumor tissues that closely replicate the human tumor microenvironment. Easier and faster to establish than traditional PDX models, PDXOs are ideal for high-throughput drug screening and personalized cancer research, offering a cost-effective and scalable preclinical platform.